Clinical Trial Update: Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects 2 Years of Age and Older

View source ↗

Summary

The clinical trial evaluating the safety of a single-dose meningococcal ACWY conjugate vaccine in subjects aged 2 years and older has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• Meningococcal ACWY Conjugate Vaccine (Meningococcal conjugate vaccine (serogroups A, C, W, Y))

Snippet

Sponsor: Novartis Vaccines | Conditions: Meningococcal Disease | Status: WITHDRAWN